ADMA Biologics Inc (ADMA)
21.30
-0.07
(-0.33%)
USD |
NASDAQ |
Nov 21, 16:00
21.29
-0.01
(-0.05%)
After-Hours: 20:00
ADMA Biologics Gross Profit Margin (Quarterly): 49.78% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 49.78% |
| June 30, 2024 | 53.60% |
| March 31, 2024 | 47.77% |
| December 31, 2023 | 42.06% |
| September 30, 2023 | 36.65% |
| June 30, 2023 | 27.76% |
| March 31, 2023 | 29.01% |
| December 31, 2022 | 28.36% |
| September 30, 2022 | 23.50% |
| June 30, 2022 | 22.92% |
| March 31, 2022 | 12.58% |
| December 31, 2021 | 13.31% |
| September 30, 2021 | 1.86% |
| June 30, 2021 | -5.62% |
| March 31, 2021 | -10.73% |
| December 31, 2020 | -36.94% |
| September 30, 2020 | -15.37% |
| June 30, 2020 | -73.30% |
| March 31, 2020 | -65.00% |
| December 31, 2019 | 2.87% |
| September 30, 2019 | -9.60% |
| June 30, 2019 | -59.90% |
| March 31, 2019 | -166.5% |
| December 31, 2018 | -174.7% |
| September 30, 2018 | -116.6% |
| Date | Value |
|---|---|
| June 30, 2018 | -107.1% |
| March 31, 2018 | -202.9% |
| December 31, 2017 | 0.67% |
| September 30, 2017 | -138.7% |
| June 30, 2017 | -27.49% |
| March 31, 2017 | 38.52% |
| December 31, 2016 | 39.46% |
| September 30, 2016 | 40.92% |
| June 30, 2016 | 40.83% |
| March 31, 2016 | 40.37% |
| December 31, 2015 | 40.18% |
| September 30, 2015 | 39.93% |
| June 30, 2015 | 39.97% |
| March 31, 2015 | 39.48% |
| December 31, 2014 | 35.73% |
| September 30, 2014 | 36.48% |
| June 30, 2014 | 37.29% |
| March 31, 2014 | 37.39% |
| December 31, 2013 | 33.40% |
| September 30, 2013 | 34.42% |
| June 30, 2013 | 34.65% |
| March 31, 2013 | 33.28% |
| December 31, 2012 | 27.33% |
| September 30, 2012 | 59.85% |
| June 30, 2012 | 38.34% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-73.30%
Minimum
Jun 2020
53.60%
Maximum
Jun 2024
9.25%
Average
18.11%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics Inc | 98.43% |
| Madrigal Pharmaceuticals Inc | 96.54% |
| Assembly Biosciences Inc | -- |
| TG Therapeutics Inc | 88.86% |
| Krystal Biotech Inc | 92.03% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 39.59% |
| Return on Assets | 18.97% |
| Return on Invested Capital | 22.77% |
| Profit Margin (Quarterly) | 29.96% |
| Operating Margin (Quarterly) | 33.08% |
| Return on Net Operating Assets | 24.46% |